Wikidata

(Q66398614)

English

A Phase 1 Study to Evaluate H3B-8800 in Participants With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia

clinical trial

In more languages

Statements

title
An Open-label, Multicenter Phase 1 Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Splicing Modulator H3B-8800 for Subjects With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia (English)
0 references
medical condition
syndrome
0 references
leukemia
0 references
country
France
0 references
Germany
0 references
Spain
0 references
start time
6 October 2016
0 references
end time
1 December 2019
0 references
number of participants
200
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q66398614&oldid=2155098435"